Wegovy starts working from the very first dose, but the effects build gradually over several months as the dose increases. Most people notice reduced appetite and some weight loss within the first few weeks at the starting dose of 0.25 mg. In clinical studies, participants lost an average of about 3.8% of their body weight after just four weeks of treatment. The full effect, however, doesn’t kick in until you reach the maintenance dose, which takes at least 17 weeks of gradual escalation.
How Wegovy Works in Your Body Right Away
Semaglutide, the active ingredient in Wegovy, mimics a hormone your gut naturally releases after eating. This hormone signals three key areas simultaneously: it acts on satiety centers in the hypothalamus to reduce hunger, it slows down how quickly your stomach empties, and it triggers insulin release from the pancreas. All three of these effects begin with the first injection.
The stomach-slowing effect is actually strongest right after your first dose and gradually diminishes over time as your body adapts. This is why many people feel noticeably fuller after meals in the first week or two, sometimes even before any weight change shows on the scale. That early fullness is a real physiological signal, not a placebo effect. Studies using endoscopy have found that people taking semaglutide are nearly five times more likely to have food still sitting in their stomach compared to people not on the medication.
The Dose Escalation Timeline
Wegovy follows a strict four-step ramp-up before reaching its full-strength maintenance dose. The schedule exists to let your digestive system adjust gradually, reducing the chance of nausea, diarrhea, and constipation that are common at higher doses.
- Weeks 1 through 4: 0.25 mg once weekly (starting dose)
- Weeks 5 through 8: 0.5 mg once weekly
- Weeks 9 through 12: 1 mg once weekly
- Weeks 13 through 16: 1.7 mg once weekly
- Week 17 onward: 2.4 mg once weekly (maintenance dose)
Each step lasts four weeks. That means the earliest you’ll reach the full maintenance dose is week 17, roughly four months after your first injection. You cannot skip steps or speed through the schedule safely.
What to Expect at Each Stage
At the 0.25 mg starting dose, you’re on the lowest amount. Even so, many people report feeling less hungry between meals and finding it easier to stop eating when they’re full. The weight loss at this stage is real but modest. That roughly 3.8% average body weight loss at four weeks translates to about 7 to 8 pounds for someone starting at 200 pounds.
As you move to 0.5 mg and then 1 mg, the appetite-suppressing effects typically become more noticeable. You may find that food occupies less mental space throughout the day, that cravings for high-calorie foods fade, and that portion sizes naturally shrink without much effort. Weight loss tends to accelerate through these middle doses.
The jump to 1.7 mg and then the 2.4 mg maintenance dose is where most people experience the medication’s peak effect. The largest clinical trials showed the majority of weight loss accumulated over the first 60 weeks, with the steepest drops occurring once participants were on the maintenance dose for several months. Semaglutide is a long-acting molecule, and it takes repeated weekly dosing at each level for drug concentrations in your blood to fully stabilize.
Why Some People Stay on Lower Doses Longer
Gastrointestinal side effects, particularly nausea, constipation, and diarrhea, tend to flare each time the dose increases. Your body usually adjusts within a few weeks at each new level, but not always. If side effects are severe or persistent, your prescriber may keep you at a given dose for an extra four weeks before moving up. The FDA label specifically allows for this kind of delay.
Staying at a lower dose longer doesn’t mean the medication isn’t working. It means your body needs more time to adapt. Some people find they lose meaningful weight even at the 1 mg or 1.7 mg level before ever reaching the full 2.4 mg dose. The escalation schedule is a minimum timeline, not a rigid requirement that you must hit 2.4 mg by week 17.
When Weight Loss Becomes Significant
The first month delivers early, visible results for most people, but the medication’s full potential unfolds over a longer horizon. The titration period (weeks 1 through 16) is essentially a ramp-up phase where your body is adjusting and you’re building toward therapeutic drug levels. Significant, sustained weight loss typically becomes clear once you’ve been on the maintenance dose for at least a few months.
If you’re not noticing any change in appetite or weight after the first four to eight weeks, it’s worth having a conversation with your prescriber. The medication’s hunger-reducing effects should be perceptible even at the lower doses for most people, though the degree varies. Some people experience a dramatic shift in hunger from the first week, while others notice a subtler, more gradual change that becomes obvious only when they look back at several weeks of eating patterns.
The key point: Wegovy is pharmacologically active from day one, but it’s designed as a slow build. The starting dose is one-tenth of the maintenance dose. Expecting dramatic results at 0.25 mg is unrealistic, but expecting no results at all is also inaccurate. Most people land somewhere in between, with appetite changes arriving first and meaningful scale changes following within the first month or two.